Virios Therapeutics, Inc. completed a business combination with Sealbond Limited, acquiring Pharmagesic (Holdings) Inc. and issuing 211,383 shares of common stock and 2,108.3854 shares of Series A Preferred Stock, while also announcing a reverse stoc
AI Assistant
DOGWOOD THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.